Hiba Ali, MD
Rheumatology · Pasadena, TXNPI 1679969448
Payments from drug & device makers
Across 335 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$868
- UCB, Inc.$566
- Radius Health, Inc.$472
- Dexcom, Inc.$393
- Johnson & Johnson$382
- plus $2K from 22 others
What the payments were for
- Food & beverage$6,50297%
- Education$2233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 98 | $2,256 |
| Amgen(2 entities) | 57 | $868 |
| UCB, Inc. | 37 | $566 |
| Radius Health, Inc. | 18 | $472 |
| Dexcom, Inc. | 33 | $393 |
| Johnson & Johnson | 15 | $382 |
| AstraZeneca(2 entities) | 18 | $373 |
| Novo Nordisk | 15 | $231 |
| Lilly USA, LLC | 8 | $228 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Mallinckrodt Enterprises LLC | 1 | $106 |
| ANI Pharmaceuticals, Inc. | 4 | $95 |
| Corcept Therapeutics | 4 | $79 |
| Boehringer Ingelheim | 3 | $68 |
| Biotronik NRO, Inc. | 2 | $57 |
| Novartis | 2 | $57 |
| GSK | 3 | $54 |
| Mallinckrodt Hospital Products Inc. | 3 | $50 |
| Pfizer | 2 | $47 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Bioventus LLC | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $24 |
| Medtronic | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Saluda Medical Americas, Inc. | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,724 in reported general payments places this provider in the 50th percentile of 512 rheumatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 41 | $324,172 |
| Taltz AutoinjectorIxekizumab | 11 | $84,479 |
| RasuvoMethotrexate/Pf | 14 | $7,544 |
| Hydroxychloroquine Sulfate | 100 | $4,797 |
| MethotrexateMethotrexate Sodium | 88 | $2,185 |
| Leflunomide | 12 | $1,105 |
| Duloxetine Hcl | 36 | $906 |
| Sulfasalazine DrSulfasalazine | 12 | $846 |
| Prednisone | 71 | $730 |
| Celecoxib | 20 | $653 |
| Alendronate Sodium | 28 | $358 |
| Tizanidine Hcl | 41 | $343 |
| Gabapentin | 27 | $340 |
| Allopurinol | 41 | $330 |
| Diclofenac Sodium | 11 | $239 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Pasadena
- Paul PickrellAustin$40.9M
- Atul SinghalMesquite$13.9M
- Shaikh AliTomball$9.8M
- Jitendra VasandaniLubbock$6.4M
- Dhiman BasuColleyville$6.2M
- Tamar BrionezThe Woodlands$5.2M
- Philip WallerHouston$4.9M
- John CushDallas$3.9M
- Sabeen NajamBaytown$3.6M
- Sanjay ChabraEl Paso$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.